Medical Cannabis
Science-led insight on therapeutic use, formulations, and clinical best practice.
Medical Cannabis · page 6
- International Regulation
Germany’s Cannabis Future: Political Posturing vs. Market Reality
Last month (January 15, 2026) Germany’s Bundesrag held a debate on the hotly contested amendments aimed at significantly restricting medical cannabis prescriptions, and potentially transforming the industry.
- International Regulation
France’s Budget Chaos Nears Resolution, Removing Major Barrier for Medical Cannabis Rollout
Earlier this week (Tuesday, January 27), France’s government survived two no-confidence votes, finally passing its contentious 2026 budget following months of political crisis that had largely paralysed non-urgent policymaking.
- Medical Cannabis
Is Europe Moving Away From Cannabis Flower? – Why Companies Are Betting on CE-Certified Devices
Last week, we reported on an emerging trend in the European medical cannabis industry, which is seeing regulators in incoming markets favour alternative modes of administration, challenging the ubiquity of dried flower.
- Medical Cannabis
UK’s First Medical Cannabis Legal Helpline Launches as Patients Navigate New Police Guidance
UK medical cannabis clinic Releaf has launched a new 24/7 on-demand legal support service for its prescribed patients, helping navigate common issues with their medication with professional guidance.
- International Regulation
Is Europe Moving Away From Cannabis Flower?
Spain’s medicines agency has published the first official guidance for medical cannabis preparations, confirming that its incoming market will exclude raw cannabis flower in favour of ‘standardised’ oral solutions prepared exclusively in hospital pharmacies.
- International Regulation
France’s First Prescriptions ‘Unlikely This Year’ Despite ‘Complete’ Framework
Last week, France’s now five-year old medical cannabis pilot programme was extended once again, providing a bridge beyond March 2026 for patients to continue secure access to their medication.
- Medical Cannabis
France Extends Medical Cannabis Access Again as Full Access Bill Remains Stuck in Limbo
Thousands of French medical cannabis patients will continue to receive their treatment for the foreseeable future, as the highly anticipated full generalised framework edges towards reality.
- Clinical Research
SOMAÍ and Universidade Lusófona Publish Peer-Reviewed Study Validating Full-Spectrum Oil Consistency
SOMAÍ, a leading EU-GMP-certified vertically integrated Multi-Country Operator (MCO) specialising in cannabinoid-based medicines, together with Universidade Lusófona, has published their 4th peer-reviewed study titled “Genotype and chemotype insights of high-THC medicinal Cannabis sativa L.: the role of SSR markers in the identification of cultivars” in the Journal of Cannabis Research.
- Medical Cannabis
Spanish Pharmacists Appeal Hospital-Only Cannabis Rule as Key Regulatory Deadline Passes Unmet
Spain represents one of the most exciting incoming additions to the European medical cannabis market this year, as one of the continent’s largest producers finally moves toward domestic patient access after years of hard-fought advocacy.
- Industry Trends
Inside the Medical Cannabis Police Guidance: Cancards, Driving, and What Patients Need to Know
Earlier this week, the first official guidance on medical cannabis for police officers in England and Wales was made public.
- Medical Cannabis
UK Police Finally Get Official Medical Cannabis Guidance More Than 7 Years After Legalisation
Over seven years after medical cannabis was legalised in the UK, the National Police Chiefs’ Council has approved the first official guidance for medical cannabis.
- International Regulation
Germany’s Medical Cannabis Bill Faces Critical Test as Experts Warn of ‘Unenforceable’ Framework
As Trump’s rescheduling executive order dominated the cannabis industry’s attention over the holiday period, Germany’s controversial medical cannabis bill quietly entered its most critical phase.
